Cancer drug shortages, subsequent price hikes remain a dark cloud over patient care centers
A vast majority of cancer centers are still grappling with generic drug shortages, according to a survey by the National Comprehensive Cancer Network (NCCN). Facilities …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
